Becker’s Healthcare Podcast Inside Healthcare Private Equity and Policy with Dr. David Klein and Joseph Mercer of Marwood Group
Feb 24, 2026
Dr. David Klein, an academic critical care physician and policy advisor at Marwood Group, and Joseph Mercer, Marwood managing director specializing in federal health policy and private equity diligence. They discuss regulatory diligence, state Medicaid and budget pressures, shifts toward home and value-based care, Medicare Advantage rule changes, compliance scrutiny, and where investors are hunting for stable, transactable healthcare plays.
AI Snips
Chapters
Transcript
Episode notes
How Marwood Built A Healthcare Diligence Engine
- Marwood evolved from a DC-to-Wall Street policy translator into a private equity diligence leader focused on federal regulatory, state payer, strategy, and compliance work.
- Typical engagements run ~3–4 weeks and synthesize regulatory, commercial payer, and strategy analysis into deliverables from ~25 to 350 slides.
Policy Is A Cornerstone Of Healthcare Deals
- David Klein frames healthcare investing as a triangle: clinical need, finance, and policy — all three must align for durable deals.
- He argues regulatory risk routinely ranks among the top three investment risks and drives deal diligence priorities.
Shift Toward Lower Cost Settings And Enabling Tech
- Investors are shifting toward care delivered outside large institutions: home care, hospice, remote monitoring, and digital tools supporting the patient journey.
- Cost pressures and fiscal restraint make revenue optimization and AI-driven workflow improvements high priorities.